Sanara MedTech Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($416k) $331k ($601k) ($2.8m) ($4.4m) ($8.0m) ($7.9m) ($4.3m) ($9.7m) ($37.6m)
Net Income (Loss) Available to Common Stockholders, Basic ($677k) $192k ($732k) ($7.9m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($8.1m) ($4.4m) ($9.9m) ($37.6m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($2.8m) ($4.4m) ($393k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($37.2m)
Net Income (Loss) Attributable to Noncontrolling Interest ($22k) ($89k) ($72k) ($155k) ($137k) ($247k) ($5k)
Depreciation, Depletion and Amortization $61k $81k $84k $120k $291k $597k $2.4m $3.7m $4.9m $3.9m
Depreciation $61k $81k $84k $30k $68k $221k $408k $456k $1.0m $176k
Amortization $65k $65k
Amortization of Debt Issuance Costs $5k $209k $280k
Amortization of Intangible Assets $90k $224k $376k $2.0m $3.2m $3.9m $2.5m
Deferred Income Tax Expense (Benefit) $0 $0 ($5.8m) $41k $49k
Share-based Payment Arrangement, Noncash Expense $0 $1.4m $2.7m $2.7m $3.4m $4.4m $5.2m
Share-based Payment Arrangement, Expense $2.7m $329k
Equity Method Investment, Other than Temporary Impairment $0
Equity Method Investment, Realized Gain (Loss) on Disposal ($1.0m) $251k $1.1m
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property ($16k) ($3k) ($41) $3k $10k
Gain (Loss) on Disposition of Property Plant Equipment $16k $3k $41 ($3k) $11k
Gain (Loss) on Extinguishment of Debt $0 $287k $0 $0 $586k
Income (Loss) from Equity Method Investments $0 ($10k) ($617k) ($380k) ($90k) ($952k)
Income Tax Expense (Benefit) $0 $0 $0 $0 $0 ($5.8m) ($48k) $49k
Operating Lease, Expense $202k $297k $434k $555k $549k
Other Nonoperating Income (Expense) ($144k) $211k ($99k) ($96k) $589k ($618k) ($1.7m) ($225k) ($3.2m) ($7.7m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($503k) ($64k) $609k $324k $961k $695k $2.3m $1.8m $4.5m $115k
Increase (Decrease) in Inventories ($91k) ($420k) $263k $1.2m $517k $1.5m ($1.4m) $1.8m
Increase (Decrease) in Accounts Payable $16k $27k ($171k) ($65k) ($66k) $167k ($302k) $531k ($424k) $814k
Accretion Expense $285k
General and Administrative Expense $3.9m $5.3m $5.7m $13.1m $18.7m $28.1m $16.7m
Goodwill $3.6m $3.6m $3.6m $3.6m
Inventory Write-down $153k $57k $0 $120k $318k $252k $540k $407k $522k $582k
Investment Income, Interest $21 $125 ($22k)
Operating Expenses $4.8m $5.4m $5.8m $13.3m $19.0m $29.2m $51.7m $61.4m $85.2m $88.3m
Derivative, Gain (Loss) on Derivative, Net $266 $44 $0
Net Cash Provided by (Used in) Operating Activities $409k ($140k) $277k ($2.2m) ($4.0m) ($4.8m) ($5.6m) ($3.2m) ($24k) $6.8m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $3k $44k $8k $183k $544k $172k $147k $265k $206k $4.6m
Net Cash Provided by (Used in) Investing Activities ($3k) ($86k) ($8k) ($1.2m) ($2.7m) ($5.3m) ($3.5m) ($10.2m) ($6.6m) ($15.0m)
Cash flows from financing activities:
Proceeds from (Payments for) Other Financing Activities ($443k) ($407k) ($136k) ($125k) ($547k)
Net Cash Provided by (Used in) Financing Activities $245k ($145k) $0 $9.8m $622k $28.3m ($627k) $9.6m $17.4m $8.9m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $18.2m ($9.7m) ($3.8m) $10.7m $701k
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $50k $11k $0 $44k $0 $711 $206 $284k $1.6m $3.4m
Income Taxes Paid, Net $0 $0 $49k